Alan Litwin
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 10
- Colorectal Cancer Treatments and Studies 9
-
- Renal cell carcinoma treatment 5
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 4
-
- Cancer Genomics and Diagnostics 5
-
- Histone Deacetylase Inhibitors Research 5
- Renal and related cancers 4
-
- Neuroendocrine Tumor Research Advances 4
- Co-authors
- John F. GibbsGregory E. WildingMarwan FakihRemedios PenetranteHyung L. KimNicholas J. HellenthalShaozeng ZhangWillie Underwood
- Journals
- Journal of Clinical Oncology (9 papers)Clinical Cancer Research (2 papers)The Journal of Urology (2 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Alan Litwin
35 papers receiving 592 citations
Peers
Comparison fields: 5 of 59
- Oncology 248
- Pulmonary and Respiratory Medicine 271
- Hepatology 56
- Cancer Research 102
- Surgery 167
Countries citing papers authored by Alan Litwin
This map shows the geographic impact of Alan Litwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Litwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Litwin more than expected).
Fields of papers citing papers by Alan Litwin
This network shows the impact of papers produced by Alan Litwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Litwin. The network helps show where Alan Litwin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alan Litwin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 35 | |
| 2 | 2009 | 24 | |
| 3 | 2009 | 42 | |
| 4 | High-dose octreotide acetate for management of gastroenteropancreatic neuroendocrine tumors. | 2009 | 37 |
| 5 | 2009 | 10 | |
| 6 | 2008 | 6 | |
| 7 | 2008 | 2 | |
| 8 | 2008 | 1 | |
| 9 | 2007 | 2 | |
| 10 | 2007 | 10 | |
| 11 | 2007 | 19 | |
| 12 | 2006 | 5 | |
| 13 | 2006 | 6 | |
| 14 | 2005 | 11 | |
| 15 | 2005 | 8 | |
| 16 | 2005 | 7 | |
| 17 | 2004 | 18 | |
| 18 | 2004 | 28 | |
| 19 | 2003 | 3 | |
| 20 | 2002 | 15 |
About Alan Litwin
Alan Litwin is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 610 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (10 papers), Colorectal Cancer Treatments and Studies (9 papers), Renal cell carcinoma treatment (5 papers), Histone Deacetylase Inhibitors Research (5 papers), Cancer Genomics and Diagnostics (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Neuroendocrine Tumor Research Advances (4 papers) and Renal and related cancers (4 papers). The work is most often cited by research in Oncology (248 citations), Pulmonary and Respiratory Medicine (271 citations) and Hepatology (56 citations). Alan Litwin has collaborated with scholars based in United States, Canada and France. Frequent co-authors include John F. Gibbs, Gregory E. Wilding, Marwan Fakih, Remedios Penetrante, Hyung L. Kim, Nicholas J. Hellenthal, Shaozeng Zhang, Willie Underwood, Lakshmi Pendyala and Renuka Iyer. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.